Financials

News Ideas Discussions Technicals Forecast Seasonals Options Bonds

Enterprise value of Mirum Pharmaceuticals, Inc.

Annual data

2019

2020

2021

2022

2023

2024

‪0.00‬

‪‪550.00 M‬‬

‪‪1.10 B‬‬

‪‪1.65 B‬‬

‪‪2.20 B‬‬

Period

Value

Change

Change %

2024

‪‪2.00 B‬‬

+‪‪773.77 M‬‬

+‪62.97‬%

2023

‪‪1.23 B‬‬

+‪‪578.06 M‬‬

+‪88.84‬%

2022

‪‪650.68 M‬‬

+‪‪191.06 M‬‬

+‪41.57‬%

2021

‪‪459.63 M‬‬

+‪‪199.63 M‬‬

+‪76.78‬%

2020

‪‪259.99 M‬‬

‪‪−190.71 M‬‬

‪−42.31‬%

2019

Quarterly data

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0.00‬

‪‪500.00 M‬‬

‪‪1.00 B‬‬

‪‪1.50 B‬‬

‪‪2.00 B‬‬

Period

Value

Change

Change %

Q4 '24

—

—

—

Q3 '24

‪‪1.90 B‬‬

+‪‪243.58 M‬‬

+‪14.73‬%

Q2 '24

‪‪1.65 B‬‬

+‪‪469.65 M‬‬

+‪39.68‬%

Q1 '24

‪‪1.18 B‬‬

‪‪−217.58 M‬‬

‪−15.53‬%

Q4 '23

‪‪1.40 B‬‬

+‪‪100.41 M‬‬

+‪7.72‬%

Q3 '23

‪‪1.30 B‬‬

+‪‪336.96 M‬‬

+‪34.96‬%

Q2 '23

‪‪963.71 M‬‬

+‪‪47.15 M‬‬

+‪5.14‬%

Q1 '23

‪‪916.57 M‬‬

+‪‪194.18 M‬‬

+‪26.88‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19